Abstract
Opioid treatment program (OTP) patients who received hepatitis C virus (HCV) care on‐site via telemedicine showed substantially greater virological response than patients who were referred to an off‐site specialist for HCV care, according to results of a study conducted at 12 New York‐based OTPs. The study's lead author told ADAW that the noteworthy results for HCV care via telehealth could suggest the value of providing care virtually for other chronic illnesses that can affect patients with opioid use disorder (OUD).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
